Skip to content
Umckaloabo (Pelargonium sidoides)

Geraniaceae · root

Umckaloabo

Pelargonium sidoides

Human clinical trialsUse with caution

Root extract mapped to human acute-bronchitis and URI-duration trials in Europe.

Safety first

Rare hepatotoxicity reports. Not pneumonia care. Identity: P. sidoides vs other geraniums.

Tradition vs trials

Traditional record. Southern African traditional root later industrialized as a European extract.

Trial literature. Specified extracts have human acute-bronchitis files. EMA has assessed Pelargonium sidoides root.

Practical ranges

Educational ranges — not a prescription. Culinary use is not an extract.

  • root extract (adults)

    European trial extracts use specified dry extracts several times daily; products are not interchangeable

    EMA HMPCEducational range only — not a prescription. A licensed clinician individualizes product, dose, and duration.

Pregnancy, nursing, children

  • Pregnancy. Avoid unless a clinician directs otherwise.
  • Nursing. Insufficient reliable data; avoid unless a clinician directs otherwise.
  • Children. Insufficient reliable data; avoid unless a clinician directs otherwise.

Contraindications

  • unexplained jaundice while using
  • known Pelargonium allergy

Key interactions

  • hepatotoxic drugs · caution

    Rare liver-injury reports.

Open drug–herb checker

Used in these diagnoses